<DOC>
	<DOCNO>NCT00489177</DOCNO>
	<brief_summary>This international study assess repeat adjustment time three lead cardiac resynchronization therapy ( CRT ) defibrillator increase likelihood benefit ( symptoms heart function ) compare usual device programming . The hypothesis QuickOpt facilitate serial optimization sense atrioventricular ( sAV ) , pace atrioventricular ( pAV ) , inter-ventricular ( VV ) time initial 9 month follow successful CRT increase rate clinical response structural remodel 12 month compare usual care .</brief_summary>
	<brief_title>Optimal Programming Improve Mechanical Indices , Symptoms Exercise Cardiac Resynchronization Therapy .</brief_title>
	<detailed_description>Cardiac resynchronization therapy ( CRT ) primarily design synchronize mechanical activity heart . While CRT beneficial average , sizable proportion patient clearly benefit ( respond ) CRT . Whether routinely optimize time atrium ventricle ( AV time ) timing leave right ventricle ( VV timing ) significantly increase likelihood patient benefit ( respond ) CRT unknown . The combination simple reliable measure functional capacity ( specific activity score [ SAS ] 6-minute walk distance ) echocardiographic measure leave ventricular ( LV ) volume ejection fraction ( EF ) practical way define response CRT . Based survey , patient receive CRT device formal optimization AV VV timing . This largely usefulness questionable significant resource require perform detailed echo measurement . A method estimate optimal sense AV ( sAV ) , pace AV ( pAV ) , VV time use intra-cardiac electrograms ( I-EGM ) develop ( QuickOptTM ) offer quick , simple inexpensive mean optimize CRT timing . However , utility QuickOptTM optimization unproven . Primary hypothesis . QuickOpt facilitate serial optimization sAV , pAV , VV time initial 9 month follow successful CRT increase rate clinical response structural remodel 12 month compare usual care . Clinical response define reduction SAS &gt; 1 class 25 % large improvement 6 minute hall walk distance 12 month versus baseline . Structural remodel define 15 % great reduction leave LV end systolic volume ≥ 5 % absolute improvement echo-derived LV EF 12 month versus baseline . Methods . Initially sub-study FREEDOM ( NCT00418314 ) . Now independent trial . Double-blind randomize comparison serial QuickOpt optimization sAV , pAV , VV timing ( QuickOpt ) versus usual care ( Usual ) patient highly symptomatic heart failure undergo CRT implantation . Stratification etiology LV dysfunction undertaken . Serial optimization sAV , pAV , VV timing perform QuickOptTM group immediately post-randomization , 3 , 6 , 9 month post-randomization . Final outcome assess 12 month post-randomization . Statistical aspect . 450 patient ( 225 / group ) provide 85 % power detect 15 % absolute improvement rate response CRT QuickOptTM versus usual care . The proportion responder compare use Mantel-Haenszel stratified analysis adjust lead position ( anterior versus non-anterior ) use intention-to-treat analysis . Overview . Up 50 site Canada , Europe , Asia United States enroll patient 36 month . Countries presently enrol patient include : Canada , United States , Switzerland , Italy , Belgium , Denmark , Austria , France , Spain , United Kingdom , Netherlands , China , Hong Kong Japan .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . CRTD indication implant SJM CRTD device VV timing compatible lead system . 2 . Able complete 6minute hall walk limit factor fatigue shortness breath . 3 . Geographically stable willing comply followup . 4 . Adequate echocardiographic image measure LV end systolic volume . 1 . Epicardial ventricular lead system . 2 . Ability walk ≥ 450 meter 6 minute 3 . Limited intrinsic atrial activity ( ≤ 40 bpm ) . 4 . Persistent permanent AF . 5 . 2° 3° heart block . 6 . Life expectancy less 1 year . 7 . Patient pregnant . 8 . Receiving IV inotropic agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>cardiac resynchronization therapy</keyword>
	<keyword>response</keyword>
	<keyword>Defibrillators</keyword>
</DOC>